VANCOUVER, BC & CAMBRIDGE, England– Vancouver’s STEM CELL Technologies and its subsidiary STEMCELL Technologies UK recently celebrated the grand opening of a new facility in Cambridge,UK.
In addition to recently taking possession of the 18,000 square foot building located in the Cambridge Research Park, the company has also now consolidated its existing UK staff into the facility, which at full capacity will house a substantial Research and Development group, as well as sales, marketing and other support staff.
Founded by Dr. Allen Eaves, STEMCELL provides specialized reagents and tools that support research on cancer and other diseases, as well as cell therapy and regenerative medicine globally. According to Eaves, who is also CEO and president of STEMCELL Technologies, the location for the new facility was a natural choice as it gives the company better access to its customers in the UK and Europe.
“STEMCELL has seen fantastic growth, and this facility will take us to the next level in supporting medical sciences research globally, as well as open our doors to the incredible biomedical expertise in the UK and Europe,” he said.
A major focus at the facility will be a state-of-the-art education and teaching lab. STEMCELL offers several standard and customized training courses and workshops, which are currently hosted within collaborating academic lab facilities. The multi-day, interactive courses are designed to help researchers develop expertise in protocols and techniques supported by STEMCELL’s products. Several of these world-class courses will soon be offered in the new Cambridge facility, making them more accessible to researchers in the UK and Europe.